| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 93,286,044 | 96,769,725 | 68,281,660 | | Cost of Revenue | 46,809,680 | 50,297,038 | 39,380,405 | | | Gross Profit | 46,476,364 | 46,472,687 | 28,901,255 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 12,088,422 | 13,788,469 | 6,634,386 | | Non Recurring |
-
|
-
|
-
| | Others | 6,114,031 | 7,287,757 | 3,495,780 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 28,273,910 | 25,396,460 | 18,771,089 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,940,746) | 1,897,090 | 975,806 | | Earnings Before Interest And Taxes | 26,333,165 | 27,293,550 | 19,746,894 | | Interest Expense | 670,757 | 118,834 | 202,677 | | Income Before Tax | 25,662,407 | 27,174,716 | 19,544,217 | | Income Tax Expense | 19,509,413 | 18,911,667 | 12,905,816 | | Minority Interest |
-
|
-
| (115,632) | | | | Net Income From Continuing Ops | 6,152,994 | 8,263,049 | 6,522,769 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 6,152,994 | 8,263,049 | 6,522,769 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,152,994 | $8,263,049 | $6,522,769 |
|
0.38% Nasdaq 
Income Statement
